Medical device maker St. Jude reports 7.6 percent rise in revenue

[April 20, 2016]  (Reuters) - St. Jude Medical Inc reported a 7.6 percent rise in quarterly revenue, helped by higher sales in its heart failure and neuromodulation businesses.

For the first quarter ended April 2, earnings attributable to the company fell to $95 million, or 33 cents per share, from $262 million, or 91 cents per share a year earlier.

In the quarter, the company recognized net after-tax charges of $164 million, or $0.57 per share, primarily related to acquisition-related costs and restructuring activities.

The company's total sales rose to $1.45 billion from $1.25 billion.

(Reporting by Amrutha Penumudi in Bengaluru; Editing by Maju Samuel)

[© 2016 Thomson Reuters. All rights reserved.]

Copyright 2016 Reuters. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.